Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Papageorgiou General Hospital |
---|---|
Information provided by: | Papageorgiou General Hospital |
ClinicalTrials.gov Identifier: | NCT00308490 |
The purpose of this study is to describe alterations of serum ferritin, transferrin saturation, soluble transferrin receptor, % hypochromic erythrocytes, % reticulocytes, reticulocyte hemoglobin content after iron loading in hemodialysis patients.
Condition | Intervention | Phase |
---|---|---|
Anemia in Chronic Renal Disease |
Drug: iron sucrose |
Phase IV |
Study Type: | Interventional |
Study Design: | Diagnostic, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment |
Official Title: | Phase IV Study of Iron Indices' Kinetics in Hemodialysis Patients |
Estimated Enrollment: | 160 |
Study Start Date: | September 2005 |
Estimated Study Completion Date: | January 2007 |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Greece | |
Papageorgiou General Hospital | |
Thessaloniki, Greece, 56429 |
Principal Investigator: | Efstathios Mitsopoulos, MD | Papageorgiou General Hospital |
Study ID Numbers: | 48/31-1-2005 |
Study First Received: | March 28, 2006 |
Last Updated: | March 12, 2007 |
ClinicalTrials.gov Identifier: | NCT00308490 |
Health Authority: | Greece: Ministry of Health and Welfare |
Ferric oxide, saccharated Renal Insufficiency Urologic Diseases Renal Insufficiency, Chronic Anemia |
Kidney Failure, Chronic Kidney Diseases Iron Kidney Failure |
Hematinics Therapeutic Uses Hematologic Agents Pharmacologic Actions |